Navigation Links
Frost & Sullivan Recognizes GE Healthcare for Strategic Leadership in Acquiring Dynamic Imaging to Grow Its Imaging Informatics Business

MOUNTAIN VIEW, Calif., March 19 /PRNewswire/ -- Based on its recent analysis of the medical imaging market, Frost & Sullivan presents GE Healthcare with the 2009 North American Frost & Sullivan Award for "Growth Strategy Leadership of the Year." The honor serves as recognition of the growth path that GE's imaging informatics business has embarked upon since the firm's acquisition of Dynamic Imaging (DI) in October 2007.


"The DI acquisition has provided GE with leading edge RIS/PACS technology and a winning business model that have consistently earned the appraisal of the market," says Frost & Sullivan Senior Industry Analyst Nadim Daher. "By capitalizing effectively on this strategic acquisition throughout the subsequent year, GE Healthcare has been able to stimulate its imaging informatics business despite challenging market conditions and saturation, while strengthening its leadership position in both the North American and global imaging informatics markets."

During the past year the newly-branded Dynamic Imaging Solutions division has helped GE Healthcare drive significant customer growth across all segments of the North American healthcare provider market including hospitals, outpatient imaging centers and physician offices. Further, the unique ability to offer Web-based RIS/PACS for any size hospital or outpatient imaging market (based upon Centricity RIS-IC and DI's acquired outpatient imaging center RIS, respectively) is a "sweet spot" in the industry, considering the increasing saturation in the PACS market and the opportune lower end of the spectrum, left otherwise underserved by GE prior to the acquisition.

Shortly after the acquisition, GE Healthcare re-branded DI's IntegradWeb PACS as GE Centricity PACS-IW. In early 2008, they began offering the PACS-IW solution based upon English character sets worldwide, while supporting local market specificities with character sets for German, Italian, French and Japanese as announced at RSNA 2008. The aggressive international expansion strategy it has launched is helping GE Healthcare increase its global footprint outside the maturing North American market, thereby creating a healthier pipeline and offering greater immunity to annual variations in each country's imaging IT market. It has also better positioned the company to the various stimulus plans being launched globally.

"In addition to strengthening GE Healthcare's ability to continue to grow its share of the imaging informatics market, the DI acquisition has also created internal synergies within the company. The collaborative efforts conducted in conjunction with the Centricity group are proving to be extremely beneficial for GE," notes Daher.

Most recently, the company has delivered on the promise of developing a Web-based diagnostic viewer, based on the PACS-IW viewer and advanced streaming technology, for Centricity PACS customers. The Centricity PACS Web Diagnostic "Web DX" which received 510K in October 2008 and was released for sale at RSNA 2008, is available to the worldwide Centricity PACS customer base and is set to benefit customer retention, considering that the importance of sophisticated tools and remote access capabilities is increasingly acknowledged in radiology.

Its Web-based architecture is just one appealing feature of the PACS-IW offering. The solution is also recognized for outstanding system performance and reliability, and garners consistently high user satisfaction ratings. As they face increasing economic pressure, PACS customers are focusing on improving their operational efficiency and workflow, and will therefore become increasingly demanding for certain features of the PACS-IW solution, such as its flexibility, scalability and cost effectiveness; its rapid implementation plan; its standards-based platform and advanced integration capabilities; its single database architecture; and anytime, anywhere access to all-online data.

Effective customer referring physician marketing programs such as the company's BOOST program, as well as the suite of physician office solutions offered by GE, are some of the ways GE assists present day PACS customers in their effort to differentiate, and grow their imaging businesses more effectively. GE is continually expanding the PACS-IW offering within the enterprise, beyond the core area of radiology. Building on the strength that DI has developed in radiology while operating as an independent vendor for many years prior to the acquisition; GE is continually utilizing its resources to extend its Web-based PACS solution to other clinical areas such as oncology and cardiology.

"Expansion through the enterprise is yet another growth path that GE has embarked upon, and through which it is capitalizing on its strategic acquisition of DI," concludes Daher. "The multifaceted growth strategy that GE Healthcare has put in effect since 2008 is revitalizing the company's imaging informatics business and fueling its growth multifold."

These developments have earned GE many successes in the market recently, and make GE Healthcare the deserving recipient of the 2009 Frost & Sullivan Growth Strategy Leadership of the Year Award in medical imaging. Each year, Frost & Sullivan presents this award to the company that has demonstrated an exceptional growth strategy within the industry.

Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About GE Healthcare

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest.

GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit

    Jake Wengroff

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Supernanny Jo Frost Joins the Partnership for a Drug-Free America in Supporting Time To Talk(TM)
2. Masimo Corporation Receives a Frost & Sullivan 2007 Industry Best Practices Award for Pulse Oximetry Leadership
3. Panomics Inc.: Recipient of the Frost & Sullivan 2007 United States Drug Discovery Technologies Entrepreneurial Company of the Year Award
4. Novadaqs SPY Imaging System named Product of the Year by Frost and Sullivan
5. Gary Tschautscher of Nonin Medical, Inc. Receives CEO of 2007 for North American Patient Monitoring From Frost & Sullivan
6. Kelloggs Frosted Flakes Gold(TM) Helps Moms Get the Gold
7. MedApps Receives Prestigious Frost & Sullivan Award
8. Nancy Frost Joins Lawson-Hawks as Employee Benefits Vice President
9. Accurays CyberKnife System Receives 2008 North American Medical Devices Product of the Year Award From Frost & Sullivan
10. Help Your Kids Earn an A for Attentiveness with a Bowl of Frosted Mini- Wheats(R) Cereal for Breakfast
11. Therapy Could Save Limbs After Frostbite
Post Your Comments:
(Date:4/22/2017)... ... April 22, 2017 , ... Brian Emmer brings ... of Sales and Business Development at OAKWORKS, Inc. Mr. Emmer is responsible ... and strategic planning for the company. Recognized industry-wide as a healthcare innovator, ...
(Date:4/21/2017)... ... 21, 2017 , ... An April 10 article in the Daily ... reveal a great deal about prehistoric ice-age dental practitioners and their primitive and, no ... to remove decayed dental matter, and that teeth were then filled with bitumen, a ...
(Date:4/21/2017)... ... ... staff at Palm Beach Face is proud to announce that their practice founder, Michael ... take place on April 23rd, the London Marathon has a long tradition of raising funds ... team EMPOWER, raising money for the international charity, Smile Train. , Started in ...
(Date:4/21/2017)... ... ... Chicago plastic surgeon, Dr. Anil R. Shah, MD , has found the ... located on the forehead usually attributed to a facial fracture. Their appearance is not ... has discovered an approach that is minimally invasive. He is an expert at this ...
(Date:4/21/2017)... ... April 21, 2017 , ... Brady (NYSE:BRC), a global leader ... and B-7569 vinyl label materials received certification for the BS5609 British ... to remain intact and legible, for use on chemical drums shipped by sea. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Research and Markets has announced ... Market Prospects: Addressing Production Complexities Through Risk Management and ... ... Pipeline and Market Prospects: Overcoming Production Complexities Through Risk ... of the current trends in the global biosimilars market, ...
(Date:4/20/2017)... Research and Markets has announced the addition of the "Global ... and Increasing Usage of Complex Biologics during the Forecast Period" ... The ... Billion in 2015 to around USD 26 Billion by 2020. ... Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during ...
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., ... specialty drug prescribing process, today announced it closed $25 million ... a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included participation ... round in 2014, and GV (formerly Google Ventures). ...
Breaking Medicine Technology: